Other
Contract with Customer, Liability
West Pharmaceutical Services Contract with Customer, Liability increased by 15.8% to $62.20M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 30.1%, from $47.80M to $62.20M. Over 5 years (FY 2020 to FY 2025), Contract with Customer, Liability shows relatively stable performance with a -1.2% CAGR.
Analysis
StatementBalance Sheet Statement
SectionOther
CategoryGrowth
SignalContext dependent
VolatilityModerate
First reportedQ4 2018
Last reportedQ1 2026
How to read this metric
An increase indicates higher deferred revenue and future service obligations, while a decrease suggests revenue is being recognized faster than new prepayments are received.
Detailed definition
This represents the obligation to transfer services to a customer for which the entity has received consideration or for...
Peer comparison
Similar to deferred revenue or contract liabilities reported by other asset management and financial services companies.
Metric ID:
other_contract_with_customer_liabilityHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $40.00M | $38.10M | $61.30M | $56.80M | $65.90M | $52.00M | $68.20M | $57.50M | $56.70M | $50.00M | $53.90M | $57.90M | $52.20M | $53.80M | $53.20M | $47.80M | $46.20M | $47.30M | $53.70M | $62.20M |
| QoQ Change | — | -4.8% | +60.9% | -7.3% | +16.0% | -21.1% | +31.2% | -15.7% | -1.4% | -11.8% | +7.8% | +7.4% | -9.8% | +3.1% | -1.1% | -10.2% | -3.3% | +2.4% | +13.5% | +15.8% |
| YoY Change | — | — | — | — | +64.8% | +36.5% | +11.3% | +1.2% | -14.0% | -3.8% | -21.0% | +0.7% | -7.9% | +7.6% | -1.3% | -17.4% | -11.5% | -12.1% | +0.9% | +30.1% |
Range$38.10M – $68.20M
CAGR+9.7%
Avg YoY Growth+4.0%
Median YoY Growth-0.3%
Current Streak3 quarters growth
Product Breakdown
| Segment | Q4 '21 |
|---|---|
| Smart Dose | $3.90M |
| Total | $61.30M |
Contract with Customer, Liability at Other Companies
Frequently Asked Questions
- What is West Pharmaceutical Services's contract with customer, liability?
- West Pharmaceutical Services (WST) reported contract with customer, liability of $62.20M in Q1 2026.
- How has West Pharmaceutical Services's contract with customer, liability changed year-over-year?
- West Pharmaceutical Services's contract with customer, liability increased by 30.1% year-over-year, from $47.80M to $62.20M.
- What is the long-term trend for West Pharmaceutical Services's contract with customer, liability?
- Over 5 years (2020 to 2025), West Pharmaceutical Services's contract with customer, liability has grown at a -1.2% compound annual growth rate (CAGR), from $57.10M to $53.70M.
- What does contract with customer, liability mean?
- The value of services owed to customers for which payment has already been received.